|
|
Article: Genset Enters Into a Chlamydiae Vaccine License Agreement with American Home Products Corporation
- Article from:
- PR Newswire
- Article date:
- August 19, 1998
CopyrightCOPYRIGHT 1998 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PARIS, Aug. 19 /PRNewswire/ -- Genset (Nasdaq: GENXY; Nouveau Marche: Genset) and Wyeth-Lederle Vaccines, a business unit of Wyeth-Ayerst Laboratories, division of American Home Products Corporation (NYSE: AHP) today announced that they have entered into an exclusive license agreement for the vaccine applications of the Chlamydia pneumoniae and Chlamydia trachomatis L2 genomic data generated by Genset.
Under the terms of the license agreement, Genset granted Wyeth-Lederle Vaccines an exclusive worldwide royalty-bearing license to its know-how and patent applications covering the entire Chlamydia pneumoniae and Chlamydia trachomatis L2 genomic sequences for ...